AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
NHTC
Natural Health Trends Corp.
There isn't enough reported data to score NHTC yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
NHTC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Strong |
NHTC's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
NHTC PE Valuation
NHTC has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
NHTC Forward outlook
There aren't enough analyst estimates for NHTC to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over NHTC on earnings quality, reporting a profit while its opponent remains loss making.
NHTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.15 | -$0.13 |
| Q2 2026 | -$0.16 | -900% |
| Q1 2026 | -$0.11 | -375% |
| Q4 2025 | -$0.08 | -260% |
| Q3 2025 | -$0.02 | -129% |
| Q2 2025 | $0.02 | -78% |
| Q1 2025 | $0.04 | -20% |
| Q4 2024 | $0.05 | 0% |
NHTC is still losing money, but far less than before: $0.15 per share over the past year, against $0.52 at its worst in late 2019.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over NHTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over NHTC on profitability, with a higher operating margin.
NHTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.6M | -20% |
| Q2 2026 | $7.6M | -23% |
| Q1 2026 | $9.2M | -14% |
| Q4 2025 | $9.7M | -10% |
| Q3 2025 | $9.5M | -11% |
| Q2 2025 | $9.8M | -6.3% |
| Q1 2025 | $10.7M | -2% |
| Q4 2024 | $10.8M | -0.8% |
NHTC's revenue has slid since its 2019 peak: $8M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.7% | +1.6 points |
| Q2 2026 | -8.5% | -5.1 points |
| Q1 2026 | -5.2% | -1.9 points |
| Q4 2025 | -6.5% | -2.6 points |
| Q3 2025 | -5.2% | -2.6 points |
| Q2 2025 | -3.4% | -1.1 points |
| Q1 2025 | -3.2% | +0.1 points |
| Q4 2024 | -3.9% | -1.7 points |
NHTC's operating margin was −3.7% last quarter, up 1.6 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
NHTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1M | -1670% |
| Q2 2026 | -$1.7M | +$4M |
| Q1 2026 | -$912K | -295% |
| Q4 2025 | -$964K | -1518% |
| Q3 2025 | $70K | +$513K |
| Q2 2025 | -$5.6M | -$2.1M |
| Q1 2025 | $468K | -13% |
| Q4 2024 | $68K | +$151K |
NHTC has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
NHTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -1K shares |
| 1 year | -25% | -2.9M shares |
| 3 years | -25% | -2.9M shares |
| 5 years | -25% | -2.8M shares |
| Available history | -21% | -2.3M shares |
NHTC has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28,000 |
| Q2 2026 | — |
| Q1 2026 | $5.9M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | $553,000 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NHTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -180.3x | Net Cash |
| Q2 2022 | -72.2x | Net Cash |
| Q1 2022 | -64.0x | Net Cash |
| Q4 2021 | -44.8x | Net Cash |
| Q3 2021 | -31.4x | Net Cash |
| Q2 2021 | -30.4x | Net Cash |
NHTC has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
NHTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 2.6 | Oversold |
NHTC's weekly RSI is 22 (oversold) and its Stochastic is 3 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
NHTC PE vs Consumer Cyclical Sector
| Metric | NHTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
NHTC has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over NHTC on trend strength, trading above more of its moving averages.
NHTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.85 | 14% below |
| 20 week MA | $1.37 | 47% below |
| 50 week MA | $2.35 | 69% below |
| 100 week MA | $3.48 | 79% below |
| 200 week MA | $4.69 | 84% below |
NHTC is in a downtrend: it's below all five of its weekly moving averages, and 84% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over NHTC on returns for 2026, with the stronger performance.
NHTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.38 | $5.15 | -4.3% |
| 2021 | $5.15 | $6.63 | +29% |
| 2022 | $6.63 | $3.57 | -46% |
| 2023 | $3.57 | $5.86 | +64% |
| 2024 | $5.86 | $4.49 | -23% |
| 2025 | $4.49 | $3.32 | -26% |
| 2026 YTD | $3.32 | $0.73 | -78% |
NHTC has finished lower in four of the last six years. It's down 78% so far in 2026.